SELLAS Life Sciences Group, Inc. (SLS) Shareholders’ equity 2019–2023
SELLAS Life Sciences Group, Inc. (SLS) shareholders’ equity at each fiscal year-end, per SEC filings.
-$8.0MFY2023 · since FY2019: $6.1M → -$8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$8.0M | -264.4% |
| FY2022 | $4.9M | -76.2% |
| FY2021 | $20.3M | -27.2% |
| FY2020 | $28.0M | +358.9% |
| FY2019 | $6.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice